The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation
Frontiers in Immunology · 2024
DOI: 10.3389/fimmu.2024.1360140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, 2024. Verfasst von Ylenia Longo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Virology, Universitätsklinikum Düsseldorf, Düsselorf, Germany. Hauptthemen laut MEDLINE: Cross-Priming, Dendritic Cells, Genetic Vectors, Receptors, Purinergic P2X7. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Modified Vaccinia Virus Ankara (MVA) is a safe vaccine vector inducing long- lasting and potent immune responses. MVA-mediated CD8 + T cell responses are optimally induced, if both, direct- and cross-presentation of viral or recombinant antigens by dendritic cells are contributing.
Methods
To improve the adaptive immune responses, we investigated the role of the purinergic receptor P2X7 (P2RX7) in MVA-infected feeder cells as a modulator of cross-presentation by non-infected dendritic cells. The infected feeder cells serve as source of antigen and provide signals that help to attract dendritic cells for antigen take up and to license these cells for cross-presentation.
Results
We demonstrate that presence of an active P2RX7 in major histocompatibility complex (MHC) class I (MHCI) mismatched feeder cells significantly enhanced MVA-mediated antigen cross-presentation. This was partly regulated by P2RX7-specific processes, such as the increased availability of extracellular particles as well as the altered cellular energy metabolism by mitochondria in the feeder cells. Furthermore, functional P2RX7 in feeder cells resulted in a delayed but also prolonged antigen expression after infection.
Discussion
We conclude that a combination of the above mentioned P2RX7-depending processes leads to significantly increased T cell activation via cross- presentation of MVA-derived antigens. To this day, P2RX7 has been mostly investigated in regards to neuroinflammatory diseases and cancer progression. However, we report for the first time the crucial role of P2RX7 for antigen- specific T cell immunity in a viral infection model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Virology, Universitätsklinikum Düsseldorf, Düsselorf, Germany.
- Institute of Molecular Medicine II, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
- Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
- Institute of Infection Immunity, University of Utrecht, Utrecht, Netherlands.
- Biological and Medical Research Center (BMFZ), Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Zitieren
APA
Longo, Y., Mascaraque, S. M., Andreacchio, G., Werner, J., Katahira, I., De Marchi, E., Pegoraro, A., Lebbink, R. J., Köhrer, K., Petzsch, P., Tao, R., Di Virgilio, F., Adinolfi, E., & Drexler, I. (2024). The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1360140
Vancouver
Longo Y, Mascaraque SM, Andreacchio G, Werner J, Katahira I, De Marchi E, et al. The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation. Frontiers in Immunology. 2024. doi:10.3389/fimmu.2024.1360140
BibTeX
@article{Longo2024,
author = {Longo, Ylenia and Mascaraque, Sara Moreno and Andreacchio, Giuseppe and Werner, Julia and Katahira, Ichiro and De Marchi, Elena and Pegoraro, Anna and Lebbink, Robert Jan and Köhrer, Karl and Petzsch, Patrick and Tao, Ronny and Di Virgilio, Francesco and Adinolfi, Elena and Drexler, Ingo},
title = {The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation},
journal = {Frontiers in Immunology},
year = {2024},
doi = {10.3389/fimmu.2024.1360140}
}
EUVIMED